Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dopamine agonists for reducing depression associated with hyperprolactinemia.

J H Mattox, M T Buckman, J Bernstein

    The Journal of Reproductive Medicine
    |August 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Revisiting Strategies for Bacterial Enumeration: The Case for Viable but Nonculturable (VBNC) Cells in Supplement Products.

    Probiotics and antimicrobial proteins·2026
    Same author

    Association between stress and physical activity by heart failure phenotype.

    European journal of cardiovascular nursing·2026
    Same author

    Black Hole Spectroscopy and Tests of General Relativity with GW250114.

    Physical review letters·2026
    Same author

    GW250114: Testing Hawking's Area Law and the Kerr Nature of Black Holes.

    Physical review letters·2025
    Same author

    Paediatric urgent dental care.

    British dental journal·2022
    Same author

    A Novel Seed-Dressing Formulation Based on an Improved Mutant Strain of <i>Trichoderma virens</i>, and Its Field Evaluation.

    Frontiers in microbiology·2019
    Same journal

    Elective Procedures in Obstetrics and Gynecology During the COVID-19 Pandemic.

    The Journal of reproductive medicine·2022
    Same journal

    Choriocarcinoma in Situ in a Partial Hydatidiform Mole A: Case Report.

    The Journal of reproductive medicine·2018
    Same journal

    Isolated Recurrent Hematotrachelos After Abdominal Myomectomy A Case Report.

    The Journal of reproductive medicine·2018
    Same journal

    Live Birth from Electively Cryopreserved Oocytes: A Feasible Option for Couples Opposed to Embryo Cryopreservation A Case Report.

    The Journal of reproductive medicine·2018
    Same journal

    Prevalence and Risk Factors of Ejaculation Failure on the Day of Operation Among Chinese Males Undergoing Assisted Reproductive Technique Treatments.

    The Journal of reproductive medicine·2018
    Same journal

    Efficacy and Safety of Perioperative Use of Epinephrine for Laparoscopic Myomectomy in Infertile Women with Symptomatic Solitary Intramural Uterine Fibroids A Randomized Clinical Trial.

    The Journal of reproductive medicine·2018
    See all related articles

    Depression in women with prolactinomas improved with dopamine agonist treatment. Discontinuing bromocriptine or pergolide led to recurring depression and increased prolactin levels.

    Area of Science:

    • Neuroendocrinology
    • Psychiatry
    • Reproductive Medicine

    Background:

    • Prolactinomas are pituitary tumors that secrete prolactin.
    • Elevated prolactin levels can impact mood and mental health.
    • Dopamine agonists are the primary treatment for prolactinomas.

    Purpose of the Study:

    • To investigate the relationship between prolactinomas and depression.
    • To assess the efficacy of dopamine agonists in treating depression associated with prolactinomas.

    Main Methods:

    • Prospective study of nine women with prolactinomas over 20 weeks.
    • Utilized three self-rating scales to assess depression.
    • Administered bromocriptine or pergolide to participants.

    Main Results:

    Related Experiment Videos

    • All nine women exhibited depression at baseline.
    • Depression symptoms significantly improved with bromocriptine or pergolide treatment.
    • Discontinuation of medication resulted in acute depression recurrence and elevated prolactin levels.

    Conclusions:

    • Dopamine agonist therapy is effective in managing depression in women with prolactinomas.
    • Prolactin levels are linked to mood regulation in these patients.
    • Long-term treatment with bromocriptine or pergolide is crucial for sustained mood improvement.